The effectiveness of anti-histamine ointment to nasal ala in the patients with allergic rhinitis and bronchial asthma

The effectiveness of anti-histamine ointment to nasal ala in the patients with allergic rhinitis and bronchial asthma - The effectiveness of anti-histamine ointment to nasal ala

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000031455

Enrollment

Registered

2018-02-23

Start date

2018-02-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

allergic rhinitis with bronchial asthma

Interventions

Diphenhydramine ointment 0.1FTU (0.04mg) will be applied to nasal ala twice a day for 2 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Brinchial asthma patients with active allergic rhinitis. No change of medications 4 weeks prior to the enrollment.

Exclusion criteria

Exclusion criteria: Those who have active dermartologic disorders around the nose. Any changes of medications 4 weeks prior to the enrollment.

Design outcomes

Primary

Measure	Time frame
Subjective effects measured by visual analogue scale and QOLby the patients.	—

Secondary

Measure	Time frame
adverse effects and objective effects measured by pulmonary function test.	—

Countries

Japan

Contacts

Public ContactMitsuhiro Kamimura

National Hospital Organization Disaster Medical Center Department of pulmonology

tdmckamimura@yahoo.co.jp042-526-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026